title: Do endothelin-receptor antagonists prevent delayed neurological deficits and poor outcomes after aneurysmal subarachnoid hemorrhage?: a meta-analysis.
abstract: OBJECTIVE
  Delayed ischemic neurological deficits (DINDs) contribute to poor outcomes after aneurysmal subarachnoid hemorrhage (SAH). Endothelin-1 is an important mediator involved in the development of vasospasm.
  
  
  METHODS
  We performed a systematic review and meta-analysis of randomized controlled trials assessing the use of endothelin-receptor antagonists (ETRAs) in patients with SAH.
  
  
  RESULTS
  Three studies met eligibility criteria, enrolling 867 patients. ETRAs significantly reduced the occurrence of DINDs (OR 0.68 [0.49 to 0.95]) and radiographic vasospasm (OR 0.31 [0.19 to 0.49]), but did not have any impact on mortality (OR 1.09 [0.69 to 1.72]) or poor neurological outcomes (OR 0.87 [0.63 to 1.20]). Any benefit of ETRAs may have been partially offset by adverse effects, including hypotension(OR 2.39 [1.37 to 4.17]) and pulmonary complications (OR 2.12 [1.51 to 2.98]).
  
  
  CONCLUSIONS
  Although ETRAs reduce radiographic vasospasm and DINDs, there is currently no evidence that they improve outcomes.
authors.forename: Andreas
authors.initials: A
authors.lastname: Kramer
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Fletcher
mesh_terms: D020520:Brain Infarction / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control; D002536:Cerebral Arteries / Q000000981:diagnostic imaging / Q000187:drug effects / Q000503:physiopathology; D065128:Endothelin Receptor Antagonists; D019332:Endothelin-1 / Q000037:antagonists & inhibitors* / Q000378:metabolism; D006801:Humans; D017063:Outcome Assessment, Health Care / Q000379:methods; D011859:Radiography; D016032:Randomized Controlled Trials as Topic; D017466:Receptors, Endothelin / Q000378:metabolism; D013345:Subarachnoid Hemorrhage / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D016896:Treatment Outcome; D020301:Vasospasm, Intracranial / Q000188:drug therapy* / Q000503:physiopathology / Q000517:prevention & control
chemical_list: D065128:Endothelin Receptor Antagonists; D019332:Endothelin-1; D017466:Receptors, Endothelin